Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine ZyCoV-D from Aug 6

"The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15, 2020, has been well tolerated," Cadila Healthcare, the listed entity of the group, said in a regulatory filing. Zydus Cadila Chairman Pankaj R Patel said the phase I dosing to establish the safety of ZyCoV-D is an important milestone.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gGwNGk
via IFTTT